Biocon Limited is an Indian biopharmaceutical company headquartered in Bangalore, active in biosimilars, generics and research services. It is one of India's largest biopharmaceutical groups.
Siddharth Mittal, appointed Managing Director and Chief Executive Officer of Syngene International in 2026, spent more than a decade at Biocon, serving as Chief Financial Officer and later as Managing Director and CEO.
